$3250 | Single User
$4650 | Site License
$5650 | Global License

Infectious Diseases In Vitro Diagnostics Market, By Product (Reagents, Instruments, and Software), By Technology (Microbiology, Molecular Diagnostics, and Immunochemistry), By Application, By End Use (Central Laboratories, and Point of Care), and By Geography (NA, EU, APAC, LATAM and MEA) – Analysis, Share, Trends, Size, & Forecast from 2020 – 2026- COVID-19 Updated
[Lowest Price Guaranteed: $3,250]

Published by AnalystView: 01 Jun 2020 | 270624 | In Stock
Related Topics: Abbott , Agencies , Drug , Gas , Healthcare , Hepatitis , Infectious Disease , Microbiology , Molecular Diagnostics , Respiratory , Roche , Software

Introduction

REPORT HIGHLIGHT

Infectious Diseases In Vitro Diagnostics market was valued at USD 16.1 billion by 2019, growing with 7.3% CAGR during the forecast period, 2020-2026

Market Dynamics

The favorable government initiatives and the rise in external funds for R&D purposes are some of the major factors driving the growth of global infectious diseases in vitro diagnostics market. In addition, the increasing geriatric population all across the globe are other key factors boosting the market growth. According to the World Population Aging Report by United Nations (UN), in 2019, the number of elderly people aged 80 years and older were estimated for 143 million and this number is projected to reach 426 million by the end of 2050. Moreover, the shift towards self-care clinical devices, growing health awareness, and the rising burden of target diseases are some of the contributors to the growth of the global market for infectious diseases IVD market. Conversely, a dearth of stringent regulatory framework and expenses associated with in-vitro diagnostic tests are predicted to hinder the market growth during the forecast period. Furthermore, the advancements in IVD kits such as improved patient compliance, sensitivity, and speed is likely to create lucrative opportunities in the global market in the coming future.

Presently, the North America region is playing a leading role in the global infectious diseases IVD market and is estimated to dominate the industry throughout the forecast. This dominance is attributed to the presence of well-established healthcare infrastructure, proactive government initiatives, and growing awareness levels of patients and practitioners in this region.

Further key findings of the report suggest:

• The reagents product segment held the largest market share in the overall market in 2019 and is expected to grow at a healthy rate during the forecast period. This is mainly due to increasing demand for point-of-care & self-test products and the growth in the number of R&D initiatives related to molecular diagnostic tools.

• The HIV tests segment valued for the majority of share in the infectious diseases IVD market in 2019 owing to the rapidly rising disease burden and highly unmet medical needs in the developing countries.

• The immunochemistry technology segment accounted for the highest revenue share in the worldwide industry in 2019, followed thoroughly by molecular diagnostics. Nevertheless, molecular diagnostics technology is projected to be the largest segment by the end of 2030. This is mainly due to the increasing demand for rapid new-age, accurate, and sensitive devices and rising penetration for diagnosing infectious diseases.

• The central laboratories end use segment emerged as the largest in 2019, which is primarily driven by the large volume of tests carried out these laboratories. On the other hand, the point-of-care (PoC) end use segment is projected to witness the highest growth rate during the period of forecast. This is majorly owing to the rising need for rapid diagnosing and the increase in initiatives intended to lessen hospital stays to bound healthcare expenditure.

• The Asia Pacific market for infectious diseases IVD is projected to record the highest growth rate in the estimated period owing to the high unmet medical needs, presence of favorable government initiatives for testing infectious disease, the rise in healthcare spending in countries such as India, China, South Korea, and an increase in disposable income in this region.

• Key participants of the overall infectious diseases IVD market include bioMérieux SA, Alere Inc., Abbott, Quidel Corporation, Orasure Technologies, Inc., F. Hoffmann-La Roche Ltd., Cepheid, Qiagen N.V., Hologic Inc., and Siemens Healthcare GmbH.

The market size and forecast for each segment and sub-segments has been considered as below:

• Historical Year – 2015 to 2018

• Base Year – 2019

• Estimated Year – 2020

• Projected Year – 2026

TARGET AUDIENCE

 Traders, Distributors, and Suppliers

 Manufacturers

 Government and Regional Agencies

 Research Organizations

 Consultants

 Distributors

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL INFECTIOUS DISEASES IN VITRO DIAGNOSTICS MARKET, BY TECHNOLOGY

 Molecular Diagnostics

 Immunochemistry

 Microbiology

 Others

GLOBAL INFECTIOUS DISEASES IN VITRO DIAGNOSTICS MARKET, BY PRODUCT

 Reagents

 Instruments

 Software

 Others

GLOBAL INFECTIOUS DISEASES IN VITRO DIAGNOSTICS MARKET, BY APPLICATION

 Gonorrhoea

 HPV

 HIV

 MRSA

 Streptococcus

 Clostridium Difficile

 VRE

 TB and Drug-resistant TB

 Gastro-intestinal Panel Testing

 Hepatitis B

 Hepatitis C

 CRE

 Respiratory Virus

 Candida

 Chlamydia

 Others

GLOBAL INFECTIOUS DISEASES IN VITRO DIAGNOSTICS MARKET, BY END USE

 Central Laboratories

 Point of Care

 Others

GLOBAL INFECTIOUS DISEASES IN VITRO DIAGNOSTICS MARKET, BY REGION

 North America

o The U.S.

o Canada

 Europe

o Germany

o France

o Italy

o Spain

o United Kingdom

o Rest of Europe

 Asia Pacific

o India

o China

o South Korea

o Japan

o Singapore

o Rest of APAC

 Latin America

o Brazil

o Mexico

o Argentina

o Rest of LATAM

 Middle East and Africa

o Saudi Arabia

o United Arab Emirates

o Rest of MEA

Table of Contents
for Infectious Diseases In Vitro Diagnostics Market, By Product (Reagents, Instruments, and Software), By Technology (Microbiology, Molecular Diagnostics, and Immunochemistry), By Application, By End Use (Central Laboratories, and Point of Care), and By Geography (NA, EU, APAC, LATAM and MEA) – Analysis, Share, Trends, Size, & Forecast from 2020 – 2026- COVID-19 Updated

  • TABLE OF CONTENT

    1. INFECTIOUS DISEASES IN VITRO DIAGNOSTICS MARKET OVERVIEW

    1.1. Study Scope

    1.2. Assumption and Methodology

    2. EXECUTIVE SUMMARY

    2.1. Market Snippet

    2.1.1. Market Snippet by Product

    2.1.2. Market Snippet by Technology

    2.1.3. Market Snippet by Application

    2.1.4. Market Snippet by End Use

    2.1.5. Market Snippet by Region

    2.2. Competitive Insights

    3. INFECTIOUS DISEASES IN VITRO DIAGNOSTICS KEY MARKET TRENDS

    3.1. Market Drivers

    3.1.1. Impact Analysis of Market Drivers

    3.2. Market Restraints

    3.2.1. Impact Analysis of Market Restraints

    3.3. Market Opportunities

    3.4. Market Future Trends

    4. INFECTIOUS DISEASES IN VITRO DIAGNOSTICS INDUSTRY STUDY

    4.1. Porter’s Five Forces Analysis

    4.2. Marketing Strategy Analysis

    4.3. Growth Prospect Mapping

    4.4. Regulatory Framework Analysis

    4.5. COVID-19 Impact Analysis

    4.5.1. Pre-COVID-19 Impact Analysis

    4.5.2. Post-COVID-19 Impact Analysis

    5. INFECTIOUS DISEASES IN VITRO DIAGNOSTICS MARKET LANDSCAPE

    5.1. Market Share Analysis

    5.2. Key Innovators

    5.3. Breakdown Data, by Key manufacturer

    5.3.1. Established Player Analysis

    5.3.2. Emerging Player Analysis

    6. INFECTIOUS DISEASES IN VITRO DIAGNOSTICS MARKET – BY PRODUCT

    6.1. Overview

    6.1.1. Segment Share Analysis, By Product, 2019 & 2026 (%)

    6.2. Reagents

    6.2.1. Overview

    6.2.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)

    6.3. Instruments

    6.3.1. Overview

    6.3.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)

    6.4. Software

    6.4.1. Overview

    6.4.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)

    6.5. Others

    6.5.1. Overview

    6.5.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)

    7. INFECTIOUS DISEASES IN VITRO DIAGNOSTICS MARKET – BY TECHNOLOGY

    7.1. Overview

    7.1.1. Segment Share Analysis, By Technology, 2019 & 2026 (%)

    7.2. Molecular Diagnostics

    7.2.1. Overview

    7.2.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)

    7.3. Immunochemistry

    7.3.1. Overview

    7.3.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)

    7.4. Microbiology

    7.4.1. Overview

    7.4.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)

    7.5. Others

    7.5.1. Overview

    7.5.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)

    8. INFECTIOUS DISEASES IN VITRO DIAGNOSTICS MARKET – BY APPLICATION

    8.1. Overview

    8.1.1. Segment Share Analysis, By Application, 2019 & 2026 (%)

    8.2. Gonorrhoea

    8.2.1. Overview

    8.2.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)

    8.3. HPV

    8.3.1. Overview

    8.3.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)

    8.4. HIV

    8.4.1. Overview

    8.4.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)

    8.5. MRSA

    8.5.1. Overview

    8.5.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)

    8.6. Streptococcus

    8.6.1. Overview

    8.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)

    8.7. Clostridium Difficile

    8.7.1. Overview

    8.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)

    8.8. VRE

    8.8.1. Overview

    8.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)

    8.9. TB and Drug-resistant TB

    8.9.1. Overview

    8.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)

    8.10. Gastro-intestinal Panel Testing

    8.10.1. Overview

    8.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)

    8.11. Hepatitis B

    8.11.1. Overview

    8.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)

    8.12. Hepatitis C

    8.12.1. Overview

    8.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)

    8.13. CRE

    8.13.1. Overview

    8.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)

    8.14. Respiratory Virus

    8.14.1. Overview

    8.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)

    8.15. Candida

    8.15.1. Overview

    8.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)

    8.16. Chlamydia

    8.16.1. Overview

    8.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)

    8.17. Others

    8.17.1. Overview

    8.17.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)

    9. INFECTIOUS DISEASES IN VITRO DIAGNOSTICS MARKET – BY END USE

    9.1. Overview

    9.1.1. Segment Share Analysis, By End Use, 2019 & 2026 (%)

    9.2. Central Laboratories

    9.2.1. Overview

    9.2.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)

    9.3. Point of Care

    9.3.1. Overview

    9.3.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)

    9.4. Others

    9.4.1. Overview

    9.4.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)

    10. INFECTIOUS DISEASES IN VITRO DIAGNOSTICS MARKET– BY GEOGRAPHY

    10.1. Introduction

    10.1.1. Segment Share Analysis, By Region, 2019 & 2026 (%)

    10.2. North America

    10.2.1. Overview

    10.2.2. Key Manufacturers in North America

    10.2.3. North America Market Size and Forecast, By Country, 2015 - 2026 (US$ Million)

    10.2.4. North America Market Size and Forecast, By Product, 2015 - 2026 (US$ Million)

    10.2.5. North America Market Size and Forecast, By Application, 2015 - 2026 (US$ Million)

    10.2.6. North America Market Size and Forecast, By End Use, 2015 - 2026 (US$ Million)

    10.2.7. North America Market Size and Forecast, By Technology, 2015 - 2026 (US$ Million)

    10.2.8. U.S.

    10.2.8.1. Overview

    10.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)

    10.2.9. Canada

    10.2.9.1. Overview

    10.2.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)

    10.3. Europe

    10.3.1. Overview

    10.3.2. Key Manufacturers in Europe

    10.3.3. Europe Market Size and Forecast, By Country, 2015 - 2026 (US$ Million)

    10.3.4. Europe Market Size and Forecast, By Product, 2015 - 2026 (US$ Million)

    10.3.5. Europe Market Size and Forecast, By Application, 2015 - 2026 (US$ Million)

    10.3.6. Europe Market Size and Forecast, By End Use, 2015 - 2026 (US$ Million)

    10.3.7. Europe Market Size and Forecast, By Technology, 2015 - 2026 (US$ Million)

    10.3.8. Germany

    10.3.8.1. Overview

    10.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)

    10.3.9. Italy

    10.3.9.1. Overview

    10.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)

    10.3.10. United Kingdom

    10.3.10.1. Overview

    10.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)

    10.3.11. France

    10.3.11.1. Overview

    10.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)

    10.3.12. Rest of Europe

    10.3.12.1. Overview

    10.3.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)

    10.4. Asia Pacific (APAC)

    10.4.1. Overview

    10.4.2. Key Manufacturers in Asia Pacific

    10.4.3. Asia Pacific Market Size and Forecast, By Country, 2015 - 2026 (US$ Million)

    10.4.4. Asia Pacific Market Size and Forecast, By Product, 2015 - 2026 (US$ Million)

    10.4.5. Asia Pacific Market Size and Forecast, By Application, 2015 - 2026 (US$ Million)

    10.4.6. Asia Pacific Market Size and Forecast, By End Use, 2015 - 2026 (US$ Million)

    10.4.7. Asia Pacific Market Size and Forecast, By Technology, 2015 - 2026 (US$ Million)

    10.4.8. India

    10.4.8.1. Overview

    10.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)

    10.4.9. China

    10.4.9.1. Overview

    10.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)

    10.4.10. Japan

    10.4.10.1. Overview

    10.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)

    10.4.11. South Korea

    10.4.11.1. Overview

    10.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)

    10.4.12. Rest of APAC

    10.4.12.1. Overview

    10.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)

    10.5. Latin America

    10.5.1. Overview

    10.5.2. Key Manufacturers in Latin America

    10.5.3. Latin America Market Size and Forecast, By Country, 2015 - 2026 (US$ Million)

    10.5.4. Latin America Market Size and Forecast, By Product, 2015 - 2026 (US$ Million)

    10.5.5. Latin America Market Size and Forecast, By Application, 2015 - 2026 (US$ Million)

    10.5.6. Latin America Market Size and Forecast, By End Use, 2015 - 2026 (US$ Million)

    10.5.7. Latin America Market Size and Forecast, By Technology, 2015 - 2026 (US$ Million)

    10.5.8. Brazil

    10.5.8.1. Overview

    10.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)

    10.5.9. Mexico

    10.5.9.1. Overview

    10.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)

    10.5.10. Argentina

    10.5.10.1. Overview

    10.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)

    10.5.11. Rest of LATAM

    10.5.11.1. Overview

    10.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)

    10.6. Middle East and Africa

    10.6.1. Overview

    10.6.2. Key Manufacturers in Middle East and Africa

    10.6.3. Middle East and Africa Market Size and Forecast, By Country, 2015 - 2026 (US$ Million)

    10.6.4. Middle East and Africa Market Size and Forecast, By Application, 2015 - 2026 (US$ Million)

    10.6.5. Middle East and Africa Market Size and Forecast, By End Use, 2015 - 2026 (US$ Million)

    10.6.6. Middle East and Africa Market Size and Forecast, By Product, 2015 - 2026 (US$ Million)

    10.6.7. Middle East and Africa Market Size and Forecast, By Technology, 2015 - 2026 (US$ Million)

    10.6.8. Saudi Arabia

    10.6.8.1. Overview

    10.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)

    10.6.9. United Arab Emirates

    10.6.9.1. Overview

    10.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)

    11. KEY VENDOR ANALYSIS

    11.1. Abbott

    11.1.1. Company Snapshot

    11.1.2. Financial Performance

    11.1.3. Product Benchmarking

    11.1.4. Strategic Initiatives

    11.2. bioMérieux SA

    11.3. Cepheid

    11.4. Qiagen N.V.

    11.5. Hologic Inc.

    11.6. Siemens Healthcare GmbH

    11.7. Alere Inc.

    11.8. Quidel Corporation

    11.9. Orasure Technologies

    11.10. F. Hoffmann-La Roche Ltd.

    12. 360 DEGREE ANALYSTVIEW

    13. APPENDIX

    13.1. Research Methodology

    13.2. References

    13.3. Abbreviations

    13.4. Disclaimer

    13.5. Contact Us

List Of Tables
in Infectious Diseases In Vitro Diagnostics Market, By Product (Reagents, Instruments, and Software), By Technology (Microbiology, Molecular Diagnostics, and Immunochemistry), By Application, By End Use (Central Laboratories, and Point of Care), and By Geography (NA, EU, APAC, LATAM and MEA) – Analysis, Share, Trends, Size, & Forecast from 2020 – 2026- COVID-19 Updated

List of Tables

TABLE List of data sources

TABLE Market drivers; Impact Analysis

TABLE Market restraints; Impact Analysis

TABLE Infectious Diseases In Vitro Diagnostics market: Product Snapshot (2018)

TABLE Segment Dashboard; Definition and Scope, by Product

TABLE Global Infectious Diseases In Vitro Diagnostics market, by Product 2015-2026 (USD Million)

TABLE Infectious Diseases In Vitro Diagnostics market: Technology Snapshot (2018)

TABLE Segment Dashboard; Definition and Scope, by Technology

TABLE Global Infectious Diseases In Vitro Diagnostics market, by Technology 2015-2026 (USD Million)

TABLE Infectious Diseases In Vitro Diagnostics market: Application Snapshot (2018)

TABLE Segment Dashboard; Definition and Scope, by Application

TABLE Global Infectious Diseases In Vitro Diagnostics market, by Application 2015-2026 (USD Million)

TABLE Infectious Diseases In Vitro Diagnostics market: End Use Snapshot (2018)

TABLE Segment Dashboard; Definition and Scope, by End Use

TABLE Global Infectious Diseases In Vitro Diagnostics market, by End Use 2015-2026 (USD Million)

TABLE Infectious Diseases In Vitro Diagnostics market: Regional snapshot (2018)

TABLE Segment Dashboard; Definition and Scope, by Region

TABLE Global Infectious Diseases In Vitro Diagnostics market, by Region 2015-2026 (USD Million)

TABLE North America Infectious Diseases In Vitro Diagnostics market, by Country, 2015-2026 (USD Million)

TABLE North America Infectious Diseases In Vitro Diagnostics market, by Product, 2015-2026 (USD Million)

TABLE North America Infectious Diseases In Vitro Diagnostics market, by Application, 2015-2026 (USD Million)

TABLE North America Infectious Diseases In Vitro Diagnostics market, by End Use, 2015-2026 (USD Million)

TABLE North America Infectious Diseases In Vitro Diagnostics market, by Technology, 2015-2026 (USD Million)

TABLE Europe Infectious Diseases In Vitro Diagnostics market, by country, 2015-2026 (USD Million)

TABLE Europe Infectious Diseases In Vitro Diagnostics market, by Application, 2015-2026 (USD Million)

TABLE Europe Infectious Diseases In Vitro Diagnostics market, by End Use, 2015-2026 (USD Million)

TABLE Europe Infectious Diseases In Vitro Diagnostics market, by Product, 2015-2026 (USD Million)

TABLE Europe Infectious Diseases In Vitro Diagnostics market, by Technology, 2015-2026 (USD Million)

TABLE Asia Pacific Infectious Diseases In Vitro Diagnostics market, by country, 2015-2026 (USD Million)

TABLE Asia Pacific Infectious Diseases In Vitro Diagnostics market, by Product, 2015-2026 (USD Million)

TABLE Asia Pacific Infectious Diseases In Vitro Diagnostics market, by Application, 2015-2026 (USD Million)

TABLE Asia Pacific Infectious Diseases In Vitro Diagnostics market, by End Use, 2015-2026 (USD Million)

TABLE Asia Pacific Infectious Diseases In Vitro Diagnostics market, by Technology, 2015-2026 (USD Million)

TABLE Latin America Infectious Diseases In Vitro Diagnostics market, by country, 2015-2026 (USD Million)

TABLE Latin America Infectious Diseases In Vitro Diagnostics market, by Product, 2015-2026 (USD Million)

TABLE Latin America Infectious Diseases In Vitro Diagnostics market, by Technology, 2015-2026 (USD Million)

TABLE Latin America Infectious Diseases In Vitro Diagnostics market, by Application, 2015-2026 (USD Million)

TABLE Latin America Infectious Diseases In Vitro Diagnostics market, by End Use, 2015-2026 (USD Million)

TABLE Middle East and Africa Infectious Diseases In Vitro Diagnostics market, by country, 2015-2026 (USD Million)

TABLE Middle East and Africa Infectious Diseases In Vitro Diagnostics market, by Product, 2015-2026 (USD Million)

TABLE Middle East and Africa Infectious Diseases In Vitro Diagnostics market, by Application, 2015-2026 (USD Million)

TABLE Middle East and Africa Infectious Diseases In Vitro Diagnostics market, by End Use, 2015-2026 (USD Million)

TABLE Middle East and Africa Infectious Diseases In Vitro Diagnostics market, by Technology, 2015-2026 (USD Million)

List Of Figures, Charts and Diagrams
in Infectious Diseases In Vitro Diagnostics Market, By Product (Reagents, Instruments, and Software), By Technology (Microbiology, Molecular Diagnostics, and Immunochemistry), By Application, By End Use (Central Laboratories, and Point of Care), and By Geography (NA, EU, APAC, LATAM and MEA) – Analysis, Share, Trends, Size, & Forecast from 2020 – 2026- COVID-19 Updated

List of Tables

TABLE List of data sources

TABLE Market drivers; Impact Analysis

TABLE Market restraints; Impact Analysis

TABLE Infectious Diseases In Vitro Diagnostics market: Product Snapshot (2018)

TABLE Segment Dashboard; Definition and Scope, by Product

TABLE Global Infectious Diseases In Vitro Diagnostics market, by Product 2015-2026 (USD Million)

TABLE Infectious Diseases In Vitro Diagnostics market: Technology Snapshot (2018)

TABLE Segment Dashboard; Definition and Scope, by Technology

TABLE Global Infectious Diseases In Vitro Diagnostics market, by Technology 2015-2026 (USD Million)

TABLE Infectious Diseases In Vitro Diagnostics market: Application Snapshot (2018)

TABLE Segment Dashboard; Definition and Scope, by Application

TABLE Global Infectious Diseases In Vitro Diagnostics market, by Application 2015-2026 (USD Million)

TABLE Infectious Diseases In Vitro Diagnostics market: End Use Snapshot (2018)

TABLE Segment Dashboard; Definition and Scope, by End Use

TABLE Global Infectious Diseases In Vitro Diagnostics market, by End Use 2015-2026 (USD Million)

TABLE Infectious Diseases In Vitro Diagnostics market: Regional snapshot (2018)

TABLE Segment Dashboard; Definition and Scope, by Region

TABLE Global Infectious Diseases In Vitro Diagnostics market, by Region 2015-2026 (USD Million)

TABLE North America Infectious Diseases In Vitro Diagnostics market, by Country, 2015-2026 (USD Million)

TABLE North America Infectious Diseases In Vitro Diagnostics market, by Product, 2015-2026 (USD Million)

TABLE North America Infectious Diseases In Vitro Diagnostics market, by Application, 2015-2026 (USD Million)

TABLE North America Infectious Diseases In Vitro Diagnostics market, by End Use, 2015-2026 (USD Million)

TABLE North America Infectious Diseases In Vitro Diagnostics market, by Technology, 2015-2026 (USD Million)

TABLE Europe Infectious Diseases In Vitro Diagnostics market, by country, 2015-2026 (USD Million)

TABLE Europe Infectious Diseases In Vitro Diagnostics market, by Application, 2015-2026 (USD Million)

TABLE Europe Infectious Diseases In Vitro Diagnostics market, by End Use, 2015-2026 (USD Million)

TABLE Europe Infectious Diseases In Vitro Diagnostics market, by Product, 2015-2026 (USD Million)

TABLE Europe Infectious Diseases In Vitro Diagnostics market, by Technology, 2015-2026 (USD Million)

TABLE Asia Pacific Infectious Diseases In Vitro Diagnostics market, by country, 2015-2026 (USD Million)

TABLE Asia Pacific Infectious Diseases In Vitro Diagnostics market, by Product, 2015-2026 (USD Million)

TABLE Asia Pacific Infectious Diseases In Vitro Diagnostics market, by Application, 2015-2026 (USD Million)

TABLE Asia Pacific Infectious Diseases In Vitro Diagnostics market, by End Use, 2015-2026 (USD Million)

TABLE Asia Pacific Infectious Diseases In Vitro Diagnostics market, by Technology, 2015-2026 (USD Million)

TABLE Latin America Infectious Diseases In Vitro Diagnostics market, by country, 2015-2026 (USD Million)

TABLE Latin America Infectious Diseases In Vitro Diagnostics market, by Product, 2015-2026 (USD Million)

TABLE Latin America Infectious Diseases In Vitro Diagnostics market, by Technology, 2015-2026 (USD Million)

TABLE Latin America Infectious Diseases In Vitro Diagnostics market, by Application, 2015-2026 (USD Million)

TABLE Latin America Infectious Diseases In Vitro Diagnostics market, by End Use, 2015-2026 (USD Million)

TABLE Middle East and Africa Infectious Diseases In Vitro Diagnostics market, by country, 2015-2026 (USD Million)

TABLE Middle East and Africa Infectious Diseases In Vitro Diagnostics market, by Product, 2015-2026 (USD Million)

TABLE Middle East and Africa Infectious Diseases In Vitro Diagnostics market, by Application, 2015-2026 (USD Million)

TABLE Middle East and Africa Infectious Diseases In Vitro Diagnostics market, by End Use, 2015-2026 (USD Million)

TABLE Middle East and Africa Infectious Diseases In Vitro Diagnostics market, by Technology, 2015-2026 (USD Million)


List of Figures

FIGURE Infectious Diseases In Vitro Diagnostics market segmentation

FIGURE Market research methodology

FIGURE Value chain analysis

FIGURE Porter’s Five Forces Analysis

FIGURE Market Attractiveness Analysis

FIGURE COVID-19 Impact Analysis

FIGURE Pre & Post COVID-19 Impact Comparision Study

FIGURE Competitive Landscape; Key company market share analysis, 2018

FIGURE Product segment market share analysis, 2019 & 2026

FIGURE Product segment market size forecast and trend analysis, 2015 to 2026 (USD Million)

FIGURE Molecular Diagnostics segment market size forecast and trend analysis, 2015 to 2026 (USD Million)

FIGURE Immunochemistry segment market size forecast and trend analysis, 2015 to 2026 (USD Million)

FIGURE Microbiology segment market size forecast and trend analysis, 2015 to 2026 (USD Million)

FIGURE Others segment market size forecast and trend analysis, 2015 to 2026 (USD Million)

FIGURE Technology segment market share analysis, 2019 & 2026

FIGURE Technology segment market size forecast and trend analysis, 2015 to 2026 (USD Million)

FIGURE Application segment market share analysis, 2019 & 2026

FIGURE Application segment market size forecast and trend analysis, 2015 to 2026 (USD Million)

FIGURE End Use segment market share analysis, 2019 & 2026

FIGURE End Use segment market size forecast and trend analysis, 2015 to 2026 (USD Million)

FIGURE Regional segment market share analysis, 2019 & 2026

FIGURE Regional segment market size forecast and trend analysis, 2015 to 2026 (USD Million)

FIGURE North America Infectious Diseases In Vitro Diagnostics market share and leading players, 2018

FIGURE Europe Infectious Diseases In Vitro Diagnostics market share and leading players, 2018

FIGURE Asia Pacific Infectious Diseases In Vitro Diagnostics market share and leading players, 2018

FIGURE Latin America Infectious Diseases In Vitro Diagnostics market share and leading players, 2018

FIGURE Middle East and Africa Infectious Diseases In Vitro Diagnostics market share and leading players, 2018

FIGURE North America Infectious Diseases In Vitro Diagnostics market share analysis by country, 2018

FIGURE U.S. Infectious Diseases In Vitro Diagnostics market size, forecast and trend analysis, 2015 to 2026 (USD Million)

FIGURE Canada Infectious Diseases In Vitro Diagnostics market size, forecast and trend analysis, 2015 to 2026 (USD Million)

FIGURE Europe Infectious Diseases In Vitro Diagnostics market share analysis by country, 2018

FIGURE Germany Infectious Diseases In Vitro Diagnostics market size, forecast and trend analysis, 2015 to 2026 (USD Million)

FIGURE Spain Infectious Diseases In Vitro Diagnostics market size, forecast and trend analysis, 2015 to 2026 (USD Million)

FIGURE Italy Infectious Diseases In Vitro Diagnostics market size, forecast and trend analysis, 2015 to 2026 (USD Million)

FIGURE UK Infectious Diseases In Vitro Diagnostics market size, forecast and trend analysis, 2015 to 2026 (USD Million)

FIGURE France Infectious Diseases In Vitro Diagnostics market size, forecast and trend analysis, 2015 to 2026 (USD Million)

FIGURE Rest of the Europe Infectious Diseases In Vitro Diagnostics market size, forecast and trend analysis, 2015 to 2026 (USD Million)

FIGURE Asia Pacific Infectious Diseases In Vitro Diagnostics market share analysis by country, 2018

FIGURE India Infectious Diseases In Vitro Diagnostics market size, forecast and trend analysis, 2015 to 2026 (USD Million)

FIGURE China Infectious Diseases In Vitro Diagnostics market size, forecast and trend analysis, 2015 to 2026 (USD Million)

FIGURE Japan Infectious Diseases In Vitro Diagnostics market size, forecast and trend analysis, 2015 to 2026 (USD Million)

FIGURE South Korea Infectious Diseases In Vitro Diagnostics market size, forecast and trend analysis, 2015 to 2026 (USD Million)

FIGURE Singapore Infectious Diseases In Vitro Diagnostics market size, forecast and trend analysis, 2015 to 2026 (USD Million)

FIGURE Rest of APAC Infectious Diseases In Vitro Diagnostics market size, forecast and trend analysis, 2015 to 2026 (USD Million)

FIGURE Latin America Infectious Diseases In Vitro Diagnostics market size, forecast and trend analysis, 2015 to 2026 (USD Million)

FIGURE Latin America Infectious Diseases In Vitro Diagnostics market share analysis by country, 2018

FIGURE Brazil Infectious Diseases In Vitro Diagnostics market size, forecast and trend analysis, 2015 to 2026 (USD Million)

FIGURE Mexico Infectious Diseases In Vitro Diagnostics market size, forecast and trend analysis, 2015 to 2026 (USD Million)

FIGURE Argentina Infectious Diseases In Vitro Diagnostics market size, forecast and trend analysis, 2015 to 2026 (USD Million)

FIGURE Rest of LATAM Infectious Diseases In Vitro Diagnostics market size, forecast and trend analysis, 2015 to 2026 (USD Million)

FIGURE Middle East and Africa Infectious Diseases In Vitro Diagnostics market size, forecast and trend analysis, 2015 to 2026 (USD Million)

FIGURE Middle East and Africa Infectious Diseases In Vitro Diagnostics market share analysis by country, 2018

FIGURE Saudi Arabia Infectious Diseases In Vitro Diagnostics market size, forecast and trend analysis, 2015 to 2026 (USD Million)

FIGURE United Arab Emirates Infectious Diseases In Vitro Diagnostics market size, forecast and trend analysis, 2015 to 2026 (USD Million)

Additional Details

Publisher

AnalystView

Publisher Information

AnalystView Market Insights is a market research and consulting firm that adopts a proactive approach to provide the diverse need for accurate and precise market research, custom research, and consulting solutions across geographies and industry verticals. Our company is led by a team of passionate, naturally curious, and strategic thinkers from different industry backgrounds.



These experts are dedicated to creating concrete market data analysis in various industries such as Healthcare, Bulk Chemicals, Semiconductors and Electronics, Foods and Beverages. We strive to develop meaningful and evidence-based research data that helps our clients, empowering organizations and brands of all sizes with strategic analysis, accurate data, and consumer trends.



We aim to be the number one choice for various clients who require credible data to make vital business decisions. We wish to be a trusted and reliable analytics partner to major business organizations.



We understand that critical business decisions can be taken only when verified, authentic information is available. Therefore, our experts work meticulously to provide our clients with the accurate data, so that they need not spend time in verifying it.



It is also our goal to help our clients ignore traditional research methods that require a large amount of capital, manpower, and most important of it all – the time. We know that these factors are precious to a company and always follow the latest research techniques that produce the required result in a short span of time.

Reference

270624 | AV78

Number of Pages

190

Report Format

PDF

AnalystView Reports

Related Reports

TitleDate PublishedPrice fromMore Details
Global Infectious Vaccines Partnering Terms and Agreements 2010 to 2016: Deal trends, players and financials
The Global Infectious Vaccines Partnering Terms and Agreements 2010 to 2016: Deal trends, players an...
01 Oct 2016 by Current Partnering USD $2,995 More Info
Global Infectious Diseases Partnering 2010-2016: Deal trends, players and financials
Global Infectious Diseases Partnering 2010 to 2016 provides the full collection of Infectious Diseas...
01 Oct 2016 by Current Partnering USD $3,495 More Info
The National Institute of Allergy and Infectious Diseases - Pharmaceuticals & Healthcare - Deals and Alliances Profile
SummaryThe National Institute of Allergy and Infectious Diseases (NIAID) a subsidiary of National In...
12 May 2016 by Global Data USD $250 More Info
Infectious Disease Research Institute - Pharmaceuticals & Healthcare - Deals and Alliances Profile
SummaryInfectious Disease Research Institute (IDRI) is a nonprofit healthcare institute that provide...
06 May 2016 by Global Data USD $250 More Info
The National Institute of Allergy and Infectious Diseases - Pharmaceuticals & Healthcare - Deals and Alliances Profile
SummaryThe National Institute of Allergy and Infectious Diseases (NIAID), a subsidiary of National I...
17 Mar 2016 by Global Data USD $250 More Info
Infectious Disease Research Institute - Pharmaceuticals & Healthcare - Deals and Alliances Profile
SummaryInfectious Disease Research Institute (IDRI) is a healthcare institute that provides various ...
10 Mar 2016 by Global Data USD $250 More Info
Italy Infectious Diagnostics Market Outlook to 2021
Italy Infectious Diagnostics Market Outlook to 2021SummaryGlobalData’s new report, "Italy Infectious...
04 Sep 2015 by Global Data USD $2,500 More Info
United Kingdom Infectious Diagnostics Market Outlook to 2021
United Kingdom Infectious Diagnostics Market Outlook to 2021SummaryGlobalData’s new report, "United ...
01 Sep 2015 by Global Data USD $2,500 More Info
France Infectious Diagnostics Market Outlook to 2021
France Infectious Diagnostics Market Outlook to 2021SummaryGlobalData’s new report, "France Infectio...
01 Sep 2015 by Global Data USD $2,500 More Info
Germany Infectious Diagnostics Market Outlook to 2021
Germany Infectious Diagnostics Market Outlook to 2021SummaryGlobalData’s new report, "Germany Infect...
01 Sep 2015 by Global Data USD $2,500 More Info

This report is published by AnalystView

AnalystView Market Insights is a market research and consulting firm that adopts a proactive approach to provide the diverse need for accurate and precise market research, custom research, and consulting solutions across geographies and industry verticals. Our company is led by a team of passionate, naturally curious, and strategic thinkers from different industry backgrounds.

These experts are dedicated to creating concrete market data analysis in various industries such as Healthcare, Bulk Chemicals, Semiconductors and Electronics, Foods and Beverages. We strive to develop meaningful and evidence-based research data that helps our clients, empowering organizations and brands of all sizes with strategic analysis, accurate data, and consumer trends.

We aim to be the number one choice for various clients who require credible data to make vital business decisions. We wish to be a trusted and reliable analytics partner to major business organizations.

We understand that critical business decisions can be taken only when verified, authentic information is available. Therefore, our experts work meticulously to provide our clients with the accurate data, so that they need not spend time in verifying it.

It is also our goal to help our clients ignore traditional research methods that require a large amount of capital, manpower, and most important of it all – the time. We know that these factors are precious to a company and always follow the latest research techniques that produce the required result in a short span of time.

Download Free Report Summary PDF

Infectious Diseases In Vitro Diagnostics Market, By Product (Reagents, Instruments, and Software), By Technology (Microbiology, Molecular Diagnostics, and Immunochemistry), By Application, By End Use (Central Laboratories, and Point of Care), and By Geography (NA, EU, APAC, LATAM and MEA) – Analysis, Share, Trends, Size, & Forecast from 2020 – 2026- COVID-19 Updated | Download PDF Summary

Download our FREE report summary PDF. It contains all the information on these web pages, plus a Proforma Invoice request form, should you need it to satisfy your company's internal order procedures.

Ordering Information

Orders are processed immediately and you will be notified of the despatch date on confirmation of your order.

Accepted Card Types

Payment

Buy now using our secure payment system.

We Stock...